Search Videos and More
Surgeon, Mother, Pioneer: Surgical Oncologist Rosalia Viterbo, MD, Is Committed to It All
Viterbo brought her experience and expertise back to her practice at Fox Chase and, in the years since, has worked with colleagues in the Division of Urology and Urologic Oncology to pioneer the use of robotics in more and more cancer surgeries.Meet Susan Sippel, Nursing Assistant in Fox Chase’s Urologic Oncology
Throughout Susan Sippel’s career at Fox Chase, three things have stood out: mentors, connecting with patients, and teamwork. She joined Fox Chase 29 years ago as a ward secretary for the Three South unit after her sister-in-law, a Fox Chase nurse, told her about the opening. Three years later, she moved into patient care as a nursing assistant—a title she’s held proudly for 26 years.CivaSheet® for precise radiation delivery for pancreatic cancer
CivaSheet®?is an FDA-approved Pd-103 brachytherapy planar radiation source that is radioactive on only one side. It is designed to safely deliver high doses of radiation to precisely targeted areas.Patient-Reported Quality of Life Research May Guide Treatment Decisions for Lower-Risk Prostate Cancer
New research from clinical investigators at Fox Chase may help men with prostate cancer in selecting the appropriate type of radiation therapy to treat their disease.Research Identifies Predictors of Concern in Post-Treatment Prostate Cancer Patients
In a recent study, Fox Chase Cancer Center researchers sought to identify predictors of concern in men who recently underwent treatment for prostate cancer.Experience and Expertise Makes Retroperitoneal Approach an Option for Renal Surgery
Robot-assisted renal surgery using retroperitoneal access requires substantial technical expertise and experience, and the urologic oncology team at Fox Chase Cancer Center is one of few local centers of excellence that offers it as a treatment option.International Collaborations Help Optimize Partial Nephrectomy Techniques
The urologic oncology team at Fox Chase Cancer Center continues to foster important international relationships in its pursuit of optimal surgical strategies for kidney cancer.Identification and Management of Immunotherapy Toxicities
The NCCN and ASCO have developed new guidelines that describe which bodily systems can be affected by immunotherapy and how to manage side effects based on their severity.Multidisciplinary Care, Specialized Clinicians Necessary for Recurrent Sarcoma Treatment
With so many different kinds of sarcoma that can be easily misdiagnosed in settings where they aren’t frequently seen, Fox Chase’s expertise in sarcoma care and its multidisciplinary team approach provide patients with more treatment options.?PARP Inhibitors Now Used for First- and Second-Line Maintenance of Ovarian Cancer
The use of PARP inhibitors has changed the way ovarian cancer is treated and has improved outcomes.Fox Chase Researchers Actively Recruiting for Breast Cancer Immunotherapy Trials
Recognizing the need for further evaluation of immunotherapy for breast cancer treatment, Fox Chase Cancer Center has opened two investigator-initiated trials exploring the use of immunotherapy for triple-negative and HER2-positive breast cancer.Retroperitoneoscopic Robot-Assisted Partial Nephrectomy on Morbidly Obese Patient with Tumor in the Upper Pole
Benjamin T. Ristau, MD, MHA, Randall A. Lee, MD, and Alexander Kutikov, MD, FACS, present a retroperitoneoscopic robot-assisted partial nephrectomy on a morbidly obese patient.

